A mutation in mannose‐phosphate‐dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy

A mutation in mannose‐phosphate‐dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy

Abstract Congenital disorders of glycosylation type I (CDG‐I) are inborn errors of metabolism, generally characterized by multisystem clinical manifestations, including developmental delay, hepatopathy, hypotonia, and skin, skeletal, and neurological abnormalities. Among others, dolichol‐phosphate‐m...

Full description

Bibliographic Details
Main Authors: Walinka vanTol, Angel Ashikov, Eckhard Korsch, Nurulamin Abu Bakar, Michèl A. Willemsen, Christian Thiel, Dirk J. Lefeber
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:JIMD Reports
Subjects:
congenital disorders of glycosylation
dolichol‐phosphate‐mannose
dystroglycanopathy
MPDU1‐CDG
Online Access:https://doi.org/10.1002/jmd2.12060

Internet

https://doi.org/10.1002/jmd2.12060

Similar Items